|
|
 |
Registry of Lobbyists - Ranya El-Masri
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 1825 | Active | | | Initial registration date | Last date of any changes | | 29-September-2018 | 17-January-2024 |
|
Lobbyist's Last Name
El-Masri |
Lobbyist's First Name
Ranya |
Middle Initial
|
|
Business Address of Lobbyist
355 St Hubert |
City
Montreal |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H2L 0A5 |
Telephone
5149726549 |
Fax
|
| |
Business or Firm Name for Lobbyist (if applicable)
GSK |
Registry of Joint Stock Companies Number
|
Business Address of Lobbyist's Business or Firm
100 Milverton Drive, Suite 800 |
City
Missisaugua |
Province/State
ON |
Country
CA |
Postal/Zip Code
L5R 4H1 |
Telephone
|
Fax
|
|
|
No other beneficiaries of lobbying activities
|
|
|
|
Description of Employer's Business:
Pharmaceutical manufacturer of innovative medications and vaccines |
| |
|
|
|
| Description |
|
| Representation relating to conditions under which innovative drugs and vaccines are marketed and reimbursed in NNS ,including under the NS Drug Plans and Formulary or under federal legislation. More specifically, representations are made to support a favourable and knowledgeable environment to implement new or improve current immunizations programs, and to emphasize the importance that the federal and prov. gov'ts respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs. GSK’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including innovative drugs, and vaccines, which are the company's main sectors of activities. |
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
